CYP3A Excipient-Based Microemulsion Prolongs the Effect of Magnolol on Ischemia Stroke Rats

Magnolol, which is a CYP3A substrate, is a well-known agent that can facilitate neuroprotection and reduce ischemic brain damage. However, a well-controlled release formulation is needed for the effective delivery of magnolol due to its poor water solubility. In this study, we have developed a formu...

Full description

Bibliographic Details
Published in:	Pharmaceutics
Main Authors:	Jiun-Wen Guo, Chih-Cheng Chien, Jiann-Hwa Chen
Format:	Article
Language:	English
Published:	MDPI AG 2020-08-01
Subjects:	magnolol microemulsion neuroprotection effect brain ischemic CYP3A
Online Access:	https://www.mdpi.com/1999-4923/12/8/737

Similar Items

Pharmacology, Toxicity, Bioavailability, and Formulation of Magnolol: An Update
by: Yiping Lin, et al.
Published: (2021-03-01)

Influence of Magnolol on the Secretion of α-Toxin by Staphylococcus aureus
by: Xu-Ming Deng, et al.
Published: (2010-03-01)

Antiandrogenic activity and bioavailability of magnolol analogs – A potential for prostate cancer therapeutics
by: Agneta Oskarsson, et al.
Published: (2023-11-01)

Magnolol and Honokiol Inhibited the Function and Expression of BCRP with Mechanism Exploration
by: Chung-Ping Yu, et al.
Published: (2021-12-01)

Study of Periodontal Bacteria in Diabetic Wistar Rats: Assessing the Anti-Inflammatory Effects of Carvacrol and Magnolol Hydrogels
by: Georgiana Ioana Potra Cicalău, et al.
Published: (2024-06-01)

The Use of Triphenyl Phosphonium Cation Enhances the Mitochondrial Antiplatelet Effect of the Compound Magnolol
by: Francisca Tellería, et al.
Published: (2023-01-01)

Semi-Synthesis and In Vitro Anti-Cancer Evaluation of Magnolol Derivatives
by: Xiao-Long Sun, et al.
Published: (2021-07-01)

Honokiol and Magnolol as Multifunctional Antioxidative Molecules for Dermatologic Disorders
by: Jui-Lung Shen, et al.
Published: (2010-09-01)

Evaluating the Magnolol Anticancer Potential in MKN-45 Gastric Cancer Cells
by: Mahsa Naghashpour, et al.
Published: (2023-02-01)

Magnolol ameliorates the accumulation of reactive oxidative stress and inflammation in diabetic periodontitis
by: Chia-Ming Liu, et al.
Published: (2021-07-01)

Magnolol and Honokiol: Two Natural Compounds with Similar Chemical Structure but Different Physicochemical and Stability Properties
by: Iris Usach, et al.
Published: (2021-02-01)

The Development of Magnolol-Loaded Intravenous Emulsion with Low Hepatotoxic Potential
by: Aleksandra Gostyńska, et al.
Published: (2023-09-01)

Inhibition of Bovine Enterovirus Infection by Magnolol via Modulating the Gut Microbiota in Mice
by: Junying Hu, et al.
Published: (2025-05-01)

Anti-Inflammatory and Antioxidant Properties of Carvacrol and Magnolol, in Periodontal Disease and Diabetes Mellitus
by: Georgiana Ioana Potra Cicalău, et al.
Published: (2021-11-01)

Magnolol promotes the autophagy of esophageal carcinoma cells by upregulating HACE1 gene expression
by: Huang Kenan, et al.
Published: (2024-04-01)

Acid-degradable magnolol-containing polymeric prodrug micelles for enhanced gastric cancer therapy
by: Dongshi Liang, et al.
Published: (2023-11-01)

Magnolol as a Potential Anticancer Agent: A Proposed Mechanistic Insight
by: Xiaofeng Wang, et al.
Published: (2022-09-01)

Assessing the Antioxidant Benefits of Topical Carvacrol and Magnolol Periodontal Hydrogel Therapy in Periodontitis Associated with Diabetes in Wistar Rats
by: Georgiana Ioana Potra Cicalău, et al.
Published: (2023-12-01)

Magnolol Induces the Extrinsic/Intrinsic Apoptosis Pathways and Inhibits STAT3 Signaling-Mediated Invasion of Glioblastoma Cells
by: Po-Fu Yueh, et al.
Published: (2021-12-01)

Amorphous solid dispersion preparation via coprecipitation improves the dissolution, oral bioavailability, and intestinal health enhancement properties of magnolol
by: Jia Cao, et al.
Published: (2023-06-01)

Polymer-Free Electrospinning of β-Cyclodextrin–Oligolactide for Magnolol and Honokiol Pharmaceutical Formulations
by: Diana-Andreea Blaj, et al.
Published: (2025-01-01)

Synthesis, Characterization and Biological Evaluation of Magnolol and Honokiol Derivatives with 1,3,5-Triazine of Metformin Cyclization
by: Cui Ren, et al.
Published: (2020-12-01)

Magnolol and honokiol: potential lead compounds for the new drug discovery in treating autoimmune diseases
by: Xian Lin, et al.
Published: (2025-04-01)

Citric Acid and Magnolol Ameliorate <i>Clostridium perfringens</i> Challenge in Broiler Chickens
by: Xieying Ding, et al.
Published: (2023-02-01)

Mechanistic insights of magnolol antimicrobial activity against Mycoplasma using untargeted metabolomic analyses
by: Hu Qiao, et al.
Published: (2023-12-01)

Antinociceptive Effect of Magnolol in a Neuropathic Pain Model of Mouse
by: Zhang X, et al.
Published: (2021-07-01)

Repurposing old natural compounds to target new pathogens: honokiol and magnolol against Candida auris
by: Mihai Mares, et al.
Published: (2024-12-01)

Transcriptomic Insights into the Antifungal Effects of Magnolol on the Growth and Mycotoxin Production of <i>Alternaria alternata</i>
by: Liuqing Wang, et al.
Published: (2020-10-01)

The Inhibitory Effect of Magnolol on the Human TWIK1 Channel Is Related to G229 and T225 Sites
by: Jintao Wang, et al.
Published: (2023-09-01)

Sulfation and Its Effect on the Bioactivity of Magnolol, the Main Active Ingredient of <i>Magnolia Officinalis</i>
by: Cong Xie, et al.
Published: (2022-09-01)

Berberine and magnolol exert cooperative effects on ulcerative colitis in mice by self-assembling into carrier-free nanostructures
by: Yida Xu, et al.
Published: (2024-09-01)

Deaggregation and Crystallization Inhibition by Small Amount of Polymer Addition for a Co-Amorphous Curcumin-Magnolol System
by: Jiawei Han, et al.
Published: (2021-10-01)

Identification and Validation of Magnolol Biosynthesis Genes in <i>Magnolia officinalis</i>
by: Yue Yang, et al.
Published: (2024-01-01)

Magnolol Reduces Atopic Dermatitis-like Symptoms in BALB/c Mice
by: Ju-Hyun Lee, et al.
Published: (2024-03-01)

Experimental Insights on the Use of Secukinumab and Magnolol in Acute Respiratory Diseases in Mice
by: Andrei Gheorghe Vicovan, et al.
Published: (2024-07-01)

Natural Magnolol ameliorates coccidiosis infected with Eimeria tenella by affecting antioxidant, anti-inflammatory, and gut microbiota of chicks
by: Jiahao Mo, et al.
Published: (2023-11-01)

Prophylactic and therapeutic potential of magnolol-loaded PLGA-PEG nanoparticles in a chronic murine model of allergic asthma
by: Junyi Wang, et al.
Published: (2023-05-01)

The effects of magnolol supplementation on growth performance, meat quality, oxidative capacity, and intestinal microbiota in broilers
by: Qian Xie, et al.
Published: (2022-04-01)

Microemulsions vs chitosan derivative-coated microemulsions for dermal delivery of 8-methoxypsoralen
by: Wu JY, et al.
Published: (2019-04-01)

Maternal Magnolol Supplementation during Pregnancy and Lactation Promotes Antioxidant Capacity, Improves Gut Health, and Alters Gut Microbiota and Metabolites of Weanling Piglets
by: Qiwen Fan, et al.
Published: (2023-06-01)